| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific
|
Oct 28, 2026 | BUY |
Strong Buy
+43.1% avg upside
38 analysts
|
$49.00
16.82% Upside
|
+1.4% | Β· |
|
ABT
Abbott Laboratories
|
Oct 21, 2026 | BUY |
Strong Buy
+8.5% avg upside
36 analysts
|
$125.00
17.79% Upside
|
+4.7% | Β· |
|
HAE
Haemonetics
|
Oct 19, 2026 | BUY |
Strong Buy
-20.9% avg upside
18 analysts
|
$130.00
8.74% Upside
|
+2.2% | Β· |
|
HYPR
Hyperfine
|
Oct 09, 2026 | BUY |
Strong Buy
+174.2% avg upside
7 analysts
|
$2.00
178.69% Upside
|
-39.8% | Β· |
|
PLSE
Pulse Biosciences
|
Oct 09, 2026 | BUY |
Strong Buy
+19.3% avg upside
8 analysts
|
$70.00
33.99% Upside
|
-16.7% | Β· |
|
EW
Edwards Lifesciences
|
Oct 09, 2026 | BUY |
Strong Buy
+10.0% avg upside
35 analysts
|
$110.00
19.48% Upside
|
+24.3% | Β· |
|
SENS
Senseonics Holdings
|
Oct 09, 2026 | HOLD |
Buy
+58.2% avg upside
13 analysts
|
β | +13.1% | Β· |
|
MMED
MiniMed Group, Inc.
|
Oct 09, 2026 | BUY |
Strong Buy
+37.6% avg upside
17 analysts
|
$28.00
53.16% Upside
|
-5.4% | Β· |
|
EMBC
Embecta Corporation
|
Oct 09, 2026 | HOLD |
Sell
+60.0% avg upside
5 analysts
|
β | +8.3% | Β· |
|
CBLL
Ceribell, Inc.
|
Sep 21, 2026 | BUY |
Strong Buy
-1.6% avg upside
8 analysts
|
$30.00
12.86% Upside
|
+7.1% | Β· |
|
KMTS
Kestra Medical Technologies Ltd.
|
Sep 15, 2026 | BUY |
Strong Buy
-4.9% avg upside
9 analysts
|
$32.00
7.72% Upside
|
+12.3% | Β· |
|
OBIO
Orchestra BioMed Holdings
|
Sep 10, 2026 | BUY |
Strong Buy
+120.0% avg upside
10 analysts
|
$10.00
69.19% Upside
|
+20.0% | Β· |
|
ATRC
Atricure
|
Aug 24, 2026 | BUY |
Strong Buy
-13.7% avg upside
15 analysts
|
$55.00
10.19% Downside
|
+16.2% | Β· |
|
IRTC
Irhythm Technologies
|
Aug 07, 2026 | BUY |
Strong Buy
+32.2% avg upside
21 analysts
|
$185.00
49.88% Upside
|
-29.9% | Β· |
|
PODD
Insulet
|
Aug 06, 2026 | HOLD |
Strong Buy
+40.0% avg upside
32 analysts
|
β | +1.2% | Β· |
|
DXCM
Dexcom
|
Jul 31, 2026 | BUY |
Strong Buy
+31.4% avg upside
33 analysts
|
$90.00
9.35% Upside
|
+3.0% | Β· |
|
DCTH
Delcath Systems
|
Jul 13, 2026 | BUY |
Strong Buy
+55.2% avg upside
12 analysts
|
$17.00
21.00% Upside
|
+50.5% | Β· |
|
XAIR
Beyond Air
|
Jul 10, 2026 | HOLD |
Strong Buy
+3809.4% avg upside
11 analysts
|
β | -74.5% | Β· |
|
ARAY
Accuray
|
Jul 07, 2026 | HOLD |
Buy
+4430.1% avg upside
9 analysts
|
β | Β· | Β· |
|
OM
Outset Medical
|
Feb 18, 2026 | BUY |
Buy
+314.8% avg upside
8 analysts
|
$15.00
272.25% Upside
|
-8.9% | Β· |
|
ESTA
Establishment Labs Holdings
|
Apr 10, 2025 | BUY |
Strong Buy
+45.5% avg upside
13 analysts
|
$62.00
0.79% Downside
|
+99.7% | Β· |
|
AFIB
Acutus Medical
|
Nov 09, 2023 | HOLD |
Sell
+619900.0% avg upside
5 analysts
|
β | Β· | Β· |
|
AAPL
Apple
|
Oct 27, 2023 | BUY |
Strong Buy
-32.7% avg upside
85 analysts
|
$150.00
56.49% Downside
|
+38.3% | Β· |
|
PEN
Penumbra
|
Jul 26, 2023 | BUY |
Buy
+3.6% avg upside
23 analysts
|
β | -41.5% | Β· |
|
VRAYQ
Viewray
|
Jul 17, 2023 | HOLD |
Strong Buy
+558333233.3% avg upside
12 analysts
|
β | Β· | Β· |
|
MDT
Medtronic
|
Feb 21, 2023 | HOLD |
Buy
+4.4% avg upside
38 analysts
|
$89.00
7.90% Downside
|
+3.9% | Β· |
|
STIM
Neuronetics
|
Dec 16, 2022 | HOLD |
Strong Buy
+160.4% avg upside
8 analysts
|
β | -66.9% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.